These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 17955491)

  • 21. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD133 is a marker of bioenergetic stress in human glioma.
    Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
    PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
    Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
    J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein.
    Zarkoob H; Taube JH; Singh SK; Mani SA; Kohandel M
    PLoS One; 2013; 8(5):e64169. PubMed ID: 23734191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypomethylation regulates CD133 expression in human gliomas.
    Tabu K; Sasai K; Kimura T; Wang L; Aoyanagi E; Kohsaka S; Tanino M; Nishihara H; Tanaka S
    Cell Res; 2008 Oct; 18(10):1037-46. PubMed ID: 18679414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.
    Tchoghandjian A; Baeza-Kallee N; Beclin C; Metellus P; Colin C; Ducray F; Adélaïde J; Rougon G; Figarella-Branger D
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S608-19. PubMed ID: 21989663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
    Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
    Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent.
    Sun Y; Kong W; Falk A; Hu J; Zhou L; Pollard S; Smith A
    PLoS One; 2009; 4(5):e5498. PubMed ID: 19430532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy.
    Wu A; Wiesner S; Xiao J; Ericson K; Chen W; Hall WA; Low WC; Ohlfest JR
    J Neurooncol; 2007 Jun; 83(2):121-31. PubMed ID: 17077937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells.
    Yao J; Zhang T; Ren J; Yu M; Wu G
    Oncol Rep; 2009 Oct; 22(4):781-7. PubMed ID: 19724856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain tumor stem cells from an adenoid glioblastoma multiforme.
    Oka N; Soeda A; Noda S; Iwama T
    Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111.
    Friedman GK; Langford CP; Coleman JM; Cassady KA; Parker JN; Markert JM; Yancey Gillespie G
    J Neurooncol; 2009 Nov; 95(2):199-209. PubMed ID: 19521665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
    Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
    Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
    Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
    Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
    Cheng RB; Ma RJ; Wang ZK; Yang SJ; Lin XZ; Rong H; Ma Y
    Mol Cell Biochem; 2011 Mar; 349(1-2):149-57. PubMed ID: 21110069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor.
    Jin F; Gao C; Zhao L; Zhang H; Wang HT; Shao T; Zhang SL; Wei YJ; Jiang XB; Zhou YP; Zhao HY
    Brain Res; 2011 Jan; 1368():82-90. PubMed ID: 20971095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.